Edward Chan

Edward ChanNaviMed Capital

Mr. Chan started working with NaviMed Capital in 2012 where he focuses on investing in privately held healthcare companies. Prior to NaviMed, Mr. Chan was part of the healthcare investment team at Siemens Venture Capital. Based out of Boston and Beijing, he evaluated and sourced healthcare deals worldwide, performed research on various market sectors and supported portfolio companies. Mr. Chan also held an investment role at SAC Capital and a marketing role at Medtronic Cardiovascular. Mr. Chan started his career developing a molecular diagnostic technology at a venture backed company. At Siemens Venture Capital, Mr. Chan was a Board Observer at MD Datacor and actively involved in the following investments: BioImagene, RadPharm, China Diagnostics, U-Systems and Cylex. Mr. Chan was a founding fellow of the Startup Leadership Program in 2007 and has mentored various start-ups to raise over $30 million in venture financing to date. Mr. Chan holds a B.S. from Johns Hopkins University and an M.B.A. from the Wharton School at the University of Pennsylvania.